LA to require vaccine proof for most indoor sites - October 7, 2021

Los Angeles approved one of the nation’s strictest vaccine mandates Wednesday – a measure that would require the shots for everyone entering locations like bars, restaurants, nail salons and gyms. Employers are seeing success with vaccine mandates, with United Airlines, Tyson Foods, New York City schools and the NBA reporting vaccination rates that top 90%. Biden to Speak About Vaccine Mandates in Chicago - The New York Times Workers face mounting pressure to get their shots — or get fired - CBS News A Mississippi news anchor is off the air after refusing a coronavirus vaccine - The Washington Post @KayleeHartung: Get your vaccine cards ready LA Republicans offered a short-term debt-limit extension, helping stave off immediate concerns about a possible government default and pushing U.S. stock future higher Thursday morning. Concerns over whether the Treasury would be able to raise money to pay its bills have weighed on investors this week. What the Debt Ceiling Means for Social Security and More - The New York Times How The Debt Ceiling Debate Impacts The Average American - Forbes @WSJecon: Negotiations on the details of a debt-limit extension went late into the night Wednesday, but a deal wasn't finalized. “We’re making good progress...I hope we can come to an agreement tomorrow [Thursday] morning,” Senate Majority Leader Chuck Schumer said. Pfizer asked federal regulators Thursday to authorize emergency use of their coronavirus vaccine for children ages 5 to 11 – a move that could help protect more than 28 million people in the U.S. Studies published Wednesday confirm that the immune protection offered by two doses of Pfizer’s COVID-19 vaccine decreases after about two months, although protection against severe disease, hospitalization and death remains strong. Heart risks rare after Pfizer Covid vaccination, study finds - NBC News Pfizer study to vaccinate whole Brazilian town against COVID-19 - Reuters Allowing people to mix COVID-19 vaccines could cut into Pfizer and Moderna’s revenue